Immune checkpoint blockade induces gut microbiota translocation that augments extraintestinal antitumor immunity
Science Immunology · 31.03.2023 · 8 (81)
DOI: 10.1126/sciimmunol.abo2003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Immunology, erschienen am 31.03.2023. Verfasst von Yongbin Choi und 14 weiteren Autor:innen. Beteiligte Einrichtung: Division of Hematology/Oncology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Melanoma. Die Arbeit wurde bisher 139-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIDDK NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Gut microbiota, specifically gut bacteria, are critical for effective immune checkpoint blockade therapy (ICT) for cancer. The mechanisms by which gut microbiota augment extraintestinal anticancer immune responses, however, are largely unknown. Here, we find that ICT induces the translocation of specific endogenous gut bacteria into secondary lymphoid organs and subcutaneous melanoma tumors. Mechanistically, ICT induces lymph node remodeling and dendritic cell (DC) activation, which facilitates the translocation of a selective subset of gut bacteria to extraintestinal tissues to promote optimal antitumor T cell responses in both the tumor-draining lymph nodes (TDLNs) and the primary tumor. Antibiotic treatment results in decreased gut microbiota translocation into mesenteric lymph nodes (MLNs) and TDLNs, diminished DC and effector CD8 + T cell responses, and attenuated responses to ICT. Our findings illuminate a key mechanism by which gut microbiota promote extraintestinal anticancer immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Hematology/Oncology, Department of Pediatrics, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
- Department of Immunology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
- Division of Hematology/Oncology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
- Department of Cell and Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
- Department of Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
- Department of Biomedical Engineering, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
ORCID-Profile: Yongbin Choi, Jake N Lichterman, Laura A Coughlin, Nicole Poulides, Suzette N Palmer, Shuheng Gan, Jiwoong Kim, Xiaowei Zhan, Yajing Gao, Bret M Evers, Lora V Hooper, Chandrashekhar Pasare, Andrew Y Koh
Förderung
- NIAID NIH HHS
- NIDDK NIH HHS
- NCI NIH HHS
- Howard Hughes Medical Institute
Zitieren
APA
Choi, Y., Lichterman, J. N., Coughlin, L. A., Poulides, N., Li, W., Del Valle, P., Palmer, S. N., Gan, S., Kim, J., Zhan, X., Gao, Y., Evers, B. M., Hooper, L. V., Pasare, C., & Koh, A. Y. (2023). Immune checkpoint blockade induces gut microbiota translocation that augments extraintestinal antitumor immunity. Science Immunology, 8(81). https://doi.org/10.1126/sciimmunol.abo2003
Vancouver
Choi Y, Lichterman JN, Coughlin LA, Poulides N, Li W, Del Valle P, et al. Immune checkpoint blockade induces gut microbiota translocation that augments extraintestinal antitumor immunity. Science Immunology. 2023;8(81). doi:10.1126/sciimmunol.abo2003
BibTeX
@article{Choi2023,
author = {Choi, Yongbin and Lichterman, Jake N and Coughlin, Laura A and Poulides, Nicole and Li, Wenling and Del Valle, Priscilla and Palmer, Suzette N and Gan, Shuheng and Kim, Jiwoong and Zhan, Xiaowei and Gao, Yajing and Evers, Bret M and Hooper, Lora V and Pasare, Chandrashekhar and Koh, Andrew Y},
title = {Immune checkpoint blockade induces gut microbiota translocation that augments extraintestinal antitumor immunity},
journal = {Science Immunology},
year = {2023},
volume = {8},
number = {81},
doi = {10.1126/sciimmunol.abo2003}
}
EUVIMED